BridgeBio Pharma, Inc. — DEF 14A Filings
7 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by BridgeBio Pharma, Inc. (BBIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Pharma, Inc. has filed 7 DEF 14A documents with the SEC since 2018. To view all SEC filings by BridgeBio Pharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
424B7
425
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001140361-25-016452 | Apr 30, 2025 | Jun 20, 2025 |
| DEF 14A | DEF 14A | 0001140361-24-022023 | Apr 25, 2024 | Jun 21, 2024 |
| DEF 14A | DEF 14A | 0001193125-23-127256 | Apr 28, 2023 | — |
| DEF 14A | DEF 14A | 0001193125-22-133557 | Apr 29, 2022 | Jun 22, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-323214 | Nov 8, 2021 | Dec 15, 2021 |
| DEF 14A | DEF 14A | 0001193125-21-145491 | Apr 30, 2021 | Jun 17, 2021 |
| DEF 14A | DEF 14A | 0001140361-20-009469 | Apr 22, 2020 | Jun 2, 2020 |